Chinese Journal of Antituberculosis ›› 2020, Vol. 42 ›› Issue (9): 962-967.doi: 10.3969/j.issn.1000-6621.2020.09.014
• Original Articles • Previous Articles Next Articles
LIANG Rui-yun, FANG Wei-jun(), REN Hui-li, LI Hui-ru, ZHANG Hui
Received:
2020-02-17
Online:
2020-09-10
Published:
2020-09-18
Contact:
FANG Wei-jun
E-mail:fangweijun9@sohu.com
LIANG Rui-yun, FANG Wei-jun, REN Hui-li, LI Hui-ru, ZHANG Hui. Study on CT manifestations of non-tuberculous mycobacterium pulmonary disease patients with and without diabetes mellitus[J]. Chinese Journal of Antituberculosis, 2020, 42(9): 962-967. doi: 10.3969/j.issn.1000-6621.2020.09.014
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2020.09.014
组别 | 例数 | 病灶分布范围 | 优势部位分布 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
单侧 | 双侧 | 单叶 | 2叶 | ≥3叶 | 上叶 | 中叶和(或)舌叶 | 下叶 | |||
A组 | 59 | 18(30.51) | 41(69.49) | 3(5.08) | 7(11.86) | 49(83.05) | 41(69.49) | 48(81.36) | 37(62.71) | |
B组 | 59 | 22(37.29) | 37(62.71) | 6(10.17) | 14(23.73) | 39(66.10) | 39(66.10) | 45(76.27) | 34(57.63) | |
χ2值 | 0.605 | 0.605 | 0.489 | 2.838 | 4.470 | 0.155 | 0.755 | 0.318 | ||
P值 | 0.473 | 0.473 | 0.484a | 0.092 | 0.035 | 0.694 | 0.385 | 0.573 |
CT征象 | A组(59例) | B组(59例) | χ2值 | P值 | ||
---|---|---|---|---|---|---|
例数 | 显示率(%) | 例数 | 显示率(%) | |||
实变影 | 21 | 35.59 | 8 | 13.56 | 7.726 | 0.005 |
空洞 | 40 | 67.80 | 29 | 49.15 | 4.223 | 0.040 |
结节状病灶 | 40 | 67.80 | 52 | 88.14 | 7.104 | 0.008 |
球状/团块状影 | 23 | 38.98 | 7 | 11.86 | 8.139 | 0.004 |
支气管扩张 | 51 | 86.44 | 48 | 81.36 | 0.565 | 0.452 |
树芽征 | 31 | 52.54 | 42 | 71.19 | 4.346 | 0.037 |
蜂窝状影 | 15 | 25.42 | 2 | 3.39 | 11.614 | 0.001 |
纵隔、肺门淋巴结肿大 | 19 | 32.20 | 12 | 20.34 | 2.144 | 0.143 |
胸膜增厚、粘连 | 3 | 5.08 | 2 | 3.39 | 0.000 | 1.000a |
心包增厚及积液 | 5 | 8.47 | 3 | 5.08 | 0.134 | 0.714a |
肺体积缩小 | 15 | 25.42 | 10 | 16.95 | 1.269 | 0.260 |
空洞CT扫描所见 | A组(59例) | B组(59例) | χ2值 | P值 | ||
---|---|---|---|---|---|---|
例数 | 显示率(%) | 例数 | 显示率(%) | |||
类型 | ||||||
薄壁空洞 | 13 | 22.03 | 23 | 38.98 | 3.997 | 0.046 |
厚壁空洞 | 33 | 55.93 | 12 | 20.34 | 15.841 | 0.000 |
分布范围(叶) | ||||||
1 | 3 | 5.08 | 5 | 8.47 | 0.136 | 0.712a |
2 | 9 | 15.25 | 13 | 22.03 | 0.222 | 0.638 |
≥3 | 35 | 59.32 | 17 | 28.81 | 11.140 | 0.001 |
数量(个) | ||||||
1 | 3 | 5.08 | 4 | 6.78 | 0.000 | 1.000a |
2 | 13 | 22.03 | 19 | 32.20 | 1.544 | 0.214 |
≥3 | 34 | 57.63 | 21 | 35.59 | 5.755 | 0.016 |
[1] |
Winthrop KL, McNelley E, Kendall B, et al. Puhnonary non-tuberculous mycobacterial disease prevalence and clinical lea-tures:an emerging public health disease. Am J Respir Crit Care Med, 2010,182(7):977-982.doi: 10.1164/rccm.201003-0503OC.
URL pmid: 20508209 |
[2] |
Prevots DR, Shaw PA, Strickland D, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systenls. Am J Respir Crit Care Med, 2010,182(7):970-976.doi: 10.1164/rccm.201002-0310OC.
URL pmid: 20538958 |
[3] |
Yang SH, Dou KF, Song WJ, et al. Prevalence of diabetes among men and women in China. New Engl J Med, 2010,362(25):2425-2426.
URL pmid: 20573933 |
[4] | 田勍, 洪天配. 美国糖尿病学会2017年版糖尿病医学诊疗标准的解读. 中国糖尿病杂志, 2017,25(7):577-581. doi: 10.3969/j.issn.1006-6187.2017.07.001. |
[5] | 中华医学会结核病学分会, 《中华结核和呼吸杂志》编辑委员会. 非结核分枝杆菌病诊断与治疗专家共识. 中华结核和呼吸杂志, 2012,35(8):572-580.doi: 10.3760/cma.j.issn.1001-0939.2012.08.006. |
[6] |
Kendall BA, Varley CD, Choi D, et al. Distinguishing tuberculosis from nontuberculous mycobaeteria lung disease, Oregon,USA. Emerg Infect Dis, 2011,17(3):506-509.doi: 10.3201/eid1703.101164.
URL pmid: 21392445 |
[7] | 李多, 张福芝, 曹宝霞, 等. 耐多药肺结核并发糖尿病患者胸部CT扫描特征分析. 中国防痨杂志, 2019,41(7):765-769.doi: 10.3969/j.issn.1000-6621.2019.07.012. |
[8] | 赵余祥, 陈金春, 王东煜, 等. 多排螺旋CT双向定量检测对糖尿病肺损伤的诊断价值. 中国基层医药, 2018,25(24):3137-3140.doi: 10.3760/cma.j.issn.1008-6706.2018.24.003. |
[9] | 李芳, 贺伟, 周新华, 等. 非结核分枝杆菌肺病和活动性肺结核的高分辨率CT表现异同性分析. 中国防痨杂志, 2018,40(5):499-505. doi: 10.3969/j.issn.1000-6621.2018.05.012. |
[10] | 吕平欣, 马大庆. 常见非结核分枝杆菌肺病的CT表现. 中华放射学杂志, 2015,49(3):238-240.doi: 10.3760/cma.j.issn.1005-1201.2015.03.022. |
[11] | Hong SJ, Kim TI, Lee JH, et al. Nontuberculous mycobacterial pulmonary disease mimicking lung canoer:clinicoradiologic features and diagnostic implications. Medicine(Baltimore), 2016,95(26):e3978. doi: 10.1097/MD.0000000000003978. |
[12] |
Tegegne BS, Haewold TD, Mengesha MM, et al. Association between diabetes mellitus and multi-drug-resistant tubereulosis:a protocol for a systematic review and meta-analysis. Systematic Reviews, 2017,6(1):6. doi: 10.1186/s13643-017-0407-9.
doi: 10.1186/s13643-017-0407-9 URL pmid: 28088237 |
[13] | 黎桂菊, 罗健, 符州. 儿童蜂窝肺的研究进展. 临床儿科杂志, 2013,31(2):194-197. doi: 10.3969/j.issn.1000-3606.2013.02.027. |
[14] |
Polverosi R, Guarise A, Balestro E, et al. High-resolution CT of nontuberculous mycobacteria pulmonary infection in immunocompetent,non-HIV-positive patients. Radiol Med, 2010,115(2):191-204.doi: 10.1007/s11547-009-0479-2.
URL pmid: 20012920 |
[15] | 周荣真, 吴秀丽, 王健, 等. 鸟-胞内分枝杆菌肺病伴空洞的CT特征分析. 中国防痨杂志, 2019,41(9):1009-1014. doi: 10.3969/j.issn.1000-6621.2019.09.018. |
[16] |
Ors F, Deniz O, Bozlar U, et al. High-resolution CT findings in patients with pulmonary tuberculosis: correlation with the degree of smear positivity. J Thorac Imaging, 2007,22(2):154-159. doi: 10.1097/01.rti.0000213590.29472.ce.
URL pmid: 17527119 |
[17] | Song Q, Zhang G, Jiang H, et al. Imaging fcatures of pulmonary CT in type 2 diabetic patients with multidrug-resistant tuberculosis. PLoS One, 2016,11(3):503-507. doi: 10.1371/journal.pone.0152507. |
[18] | 任会丽, 陈品儒, 陈华, 等. 鸟-胞内分枝杆菌复合群与龟-脓肿分枝杆菌肺病并发支气管扩张的CT征象比较. 中国防痨杂志, 2019,41(2):195-201.doi: 10.3969/j.issn.1000-6621.2019.02.014. |
[1] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[2] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[3] | Song Feier, Mao Yanjun, Xia Qiuyue, Zhou Yang, Lin Huan. The prevalence and influencing factors of post-tuberculosis lung disease: A Meta-analysis [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 322-330. |
[4] | Zhang Guoqin, Qu Ting, Meng Qinglin, Zhou Lin, Liu Eryong. Implementation update of strategy for the control of tuberculosis and HIV/AIDS co-infection in China [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 12-17. |
[5] | Huang Tao, Jian Huiyong, Wang Xinqi, Liu Nianqiang, Yipar Aihaiti, Wang Mingzhe, Jiayinati Jingesi, Wang Senlu. Analysis of influencing factors of treatment outcomes in patients with pulmonary tuberculosis complicated with diabetes mellitus in Xinjiang Uygur Autonomous Region [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1083-1088. |
[6] | Yang Liangzi, Zhang Peize, Lu Shuihua. Interpretation of World Health Organization’s Co-administration of Treatment for Drug-resistant Tuberculosis and Hepatitis C: 2024 Update [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 874-876. |
[7] | Liu Ling, Zeng Yi, Wang Jin, Liu Xiaoling, Liu Yan, Lin Feishen, Guo Jing. Construction and evaluation of a model for predicting malnutrition in patients with pulmonary tuberculosis and diabetes mellitus [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 903-909. |
[8] | Cai Qinghe, Fu Hui, Chen Ruiming, Fan Youming, Yang Qingwei. Analysis of the clinical characteristics and influencing factors of pulmonary tuberculosis patients with diabetes mellitus in Shantou City from 2016 to 2022 [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 926-934. |
[9] | Jiang Bijia, Chen Cheng, Zhou Jinyi, Zhu Limei, Su Jian, Lu Wei. Analysis of tuberculosis incidence and influencing factors in type 2 diabetic patients in community [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 951-957. |
[10] | Tan Shouyong. Research progress on comprehensive treatment beyond antibiotic therapy for nontuberculous mycobacterium pulmonary disease [J]. Chinese Journal of Antituberculosis, 2024, 46(8): 967-970. |
[11] | Chai Dongyu, Qin Shuyi, Zhang Ronghua, Zou Nannan, Wang Xin. Analysis of risk factors for viral pneumonia combined with invasive pulmonary mycosis [J]. Chinese Journal of Antituberculosis, 2024, 46(7): 750-755. |
[12] | Fu Keyan, Zhu Bangzheng, Ye Jian. Research progress on interstitial lung disease combined with Mycobacterium tuberculosis infection [J]. Chinese Journal of Antituberculosis, 2024, 46(7): 823-829. |
[13] | Han Wenya, Zhou Yangyu, Wang Meifang, Xue Xinying. Progress in clinical diagnosis and treatment of pulmonary cryptococcosis [J]. Chinese Journal of Antituberculosis, 2024, 46(7): 830-838. |
[14] | Liu Guizhen, Deng Guofang. Interpretation of Evidence and research gaps identified during development of policy guidelines for tuberculosis (Second edition): tuberculosis related comorbidity [J]. Chinese Journal of Antituberculosis, 2024, 46(6): 618-624. |
[15] | Li Yao, Fang Zhe, Luo Danlin, Hu Yanmei, Tang Mi, Tang Zhigang, Wen Xinmin, Zhang Yong, Yao Bibo, Wang Qi, Yi Hengzhong. Clinical characteristics and prognosis of patients with novel coronavirus infection complicated with pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(6): 687-698. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||